X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (16071) 16071
Book Review (3588) 3588
Publication (1726) 1726
Book Chapter (200) 200
Book / eBook (79) 79
Newspaper Article (79) 79
Dissertation (42) 42
Conference Proceeding (37) 37
Newsletter (24) 24
Magazine Article (17) 17
Trade Publication Article (8) 8
Government Document (7) 7
Reference (5) 5
Report (5) 5
Transcript (4) 4
Data Set (3) 3
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (12935) 12935
humans (8959) 8959
parkinson's disease (7818) 7818
neurosciences (7012) 7012
animals (6711) 6711
parkinsons-disease (6344) 6344
male (5472) 5472
female (3850) 3850
clinical neurology (3343) 3343
neurology (3173) 3173
aged (2642) 2642
mice (2622) 2622
neurodegenerative diseases (2564) 2564
middle aged (2451) 2451
neurons (2441) 2441
alzheimers-disease (2315) 2315
brain (2313) 2313
neurodegeneration (2290) 2290
rats (2257) 2257
oxidative stress (2245) 2245
alpha-synuclein (2206) 2206
parkinsons disease (2176) 2176
dopamine (2144) 2144
analysis (2051) 2051
parkinson’s disease (1961) 1961
movement disorders (1956) 1956
parkinson disease - pathology (1850) 1850
disease models, animal (1836) 1836
biochemistry & molecular biology (1716) 1716
nervous system diseases (1672) 1672
proteins (1595) 1595
nervous system (1501) 1501
alzheimer's disease (1498) 1498
cell biology (1494) 1494
parkinson disease - metabolism (1468) 1468
research (1449) 1449
dementia (1408) 1408
article (1376) 1376
pathology (1361) 1361
adult (1343) 1343
substantia-nigra (1296) 1296
neurons - metabolism (1291) 1291
apoptosis (1256) 1256
brain - pathology (1242) 1242
dopamine - metabolism (1231) 1231
mice, inbred c57bl (1137) 1137
parkinson disease - physiopathology (1135) 1135
basal ganglia (1109) 1109
parkinson disease (1106) 1106
aged, 80 and over (1102) 1102
mutation (1089) 1089
rodents (1085) 1085
physiological aspects (1077) 1077
pharmacology & pharmacy (1074) 1074
neurons - pathology (1037) 1037
immunohistochemistry (1011) 1011
rats, sprague-dawley (1004) 1004
disease (1000) 1000
medicine (1000) 1000
alpha-synuclein - metabolism (997) 997
brain - metabolism (995) 995
multidisciplinary sciences (988) 988
lewy bodies (970) 970
parkinson disease - genetics (970) 970
research article (963) 963
psychiatry (953) 953
neuroprotection (945) 945
substantia nigra - pathology (912) 912
inflammation (905) 905
substantia nigra (886) 886
mitochondria (863) 863
neurons - drug effects (861) 861
risk factors (845) 845
biomedicine (843) 843
care and treatment (837) 837
diagnosis (835) 835
parkinson disease - complications (833) 833
medical research (821) 821
health aspects (803) 803
gene expression (801) 801
cells, cultured (797) 797
magnetic resonance imaging (796) 796
parkinson disease, secondary - chemically induced (793) 793
tyrosine 3-monooxygenase - metabolism (789) 789
neurotoxicity (775) 775
dopaminergic-neurons (774) 774
α-synuclein (751) 751
science (744) 744
mptp (737) 737
degeneration (734) 734
expression (732) 732
parkinson disease - drug therapy (730) 730
substantia nigra - metabolism (727) 727
genetic aspects (721) 721
mouse model (718) 718
medicine & public health (711) 711
studies (711) 711
synuclein (707) 707
microglia (683) 683
alzheimers disease (666) 666
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (56) 56
Collection Dvlpm't (Acquisitions) - Closed Orders (4) 4
Providence Healthcare - Stacks (4) 4
Online Resources - Online (3) 3
UofT at Mississauga - Stacks (3) 3
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
UofT at Scarborough - Stacks (2) 2
Baycrest Hospital - Missing (1) 1
Baycrest Hospital - Wellness Library (1) 1
Credit Valley Hospital - Online (1) 1
Credit Valley Hospital - Reserve desk (1) 1
Credit Valley Hospital - Stacks (1) 1
Gerstein Science - Circulation Desk (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Music - Stacks (1) 1
Robarts - Stacks (1) 1
Scarborough Hospital - General (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
Stacks (1) 1
Sunnybrook Health Sciences Centre - Online (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Reference (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
Trillium Health Centre - Reserve desk (1) 1
Trinity College (John W Graham) - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
University College (Laidlaw) - Stacks (1) 1
UofT Schools - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (16325) 16325
French (27) 27
Japanese (27) 27
Spanish (22) 22
German (20) 20
Chinese (14) 14
Russian (9) 9
Hungarian (3) 3
Ukrainian (3) 3
Italian (2) 2
Polish (2) 2
Portuguese (2) 2
Turkish (2) 2
Korean (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Scientific Reports, ISSN 2045-2322, 2012, Volume 2, Issue 1, pp. 898 - 898
Journal Article
Journal of Biological Chemistry, ISSN 0021-9258, 05/2011, Volume 286, Issue 18, pp. 16504 - 16515
Journal Article
Experimental Neurology, ISSN 0014-4886, 05/2012, Volume 235, Issue 1, pp. 306 - 315
Development of relevant models of Parkinson's disease (PD) is essential for a better understanding of the pathological processes underlying the human disease... 
Axonopathy | Animal models | Behavioural test | Neurodegeneration | AAV | SYSTEM | LESION MODEL | MOTOR FUNCTION | SUBSTANTIA-NIGRA | NEUROSCIENCES | DOPAMINE NEURONS | OVEREXPRESSION | RECOVERY | GDNF | GENE-TRANSFER | STRIATUM | Substantia Nigra - physiopathology | Neurons - pathology | Substantia Nigra - pathology | Nerve Degeneration - physiopathology | Motor Activity - drug effects | Nerve Degeneration - genetics | Substantia Nigra - metabolism | Corpus Striatum - metabolism | Nerve Degeneration - metabolism | Medial Forebrain Bundle - physiopathology | Parkinson Disease, Secondary - pathology | Medial Forebrain Bundle - pathology | Parkinson Disease, Secondary - metabolism | Behavior, Animal - drug effects | Female | Neurons - metabolism | alpha-Synuclein - genetics | Neurons - drug effects | Corpus Striatum - pathology | Disease Models, Animal | Corpus Striatum - physiopathology | Rats | Behavior, Animal - physiology | Oxidopamine - poisoning | Rats, Sprague-Dawley | Nerve Degeneration - pathology | Motor Activity - genetics | Substantia Nigra - drug effects | Animals | Parkinson Disease, Secondary - genetics | Parkinson Disease, Secondary - physiopathology | Corpus Striatum - drug effects | Medial Forebrain Bundle - metabolism | alpha-Synuclein - metabolism | Index Medicus | Medial forebrain bundle | Dopamine | Parkinson's disease | Neurodegenerative diseases | Neurons | Therapeutic applications | 6-Hydroxydopamine | Synuclein | Cell death | Neostriatum | Toxins | MPTP | Movement disorders | Neurologi | Clinical Medicine | Neurology | Medical and Health Sciences | Medicin och hälsovetenskap | Klinisk medicin
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 02/2017, Volume 127, Issue 2, pp. 720 - 734
Journal Article
Nature Communications, ISSN 2041-1723, 12/2018, Volume 9, Issue 1, pp. 817 - 17
Neuronal loss in Parkinson's disease (PD) is associated with aberrant mitochondrial function and impaired proteostasis. Identifying the mechanisms that link... 
CIRCULAR-DICHROISM SPECTRA | DOPAMINE NEURONS | CELLS | IN-VITRO | PROTEIN SECONDARY STRUCTURE | MULTIDISCIPLINARY SCIENCES | LEWY BODY DISEASE | MITOPHAGY | NEURONAL CULTURES | AGGREGATION | PARKINSONS-DISEASE | Embryonic Stem Cells - metabolism | Neurons - pathology | Cardiolipins - pharmacology | Embryonic Stem Cells - cytology | Microtubule-Associated Proteins - genetics | Microtubule-Associated Proteins - metabolism | Humans | Male | Protein Transport - drug effects | Mitochondria - ultrastructure | Mitochondrial Membranes - drug effects | Parkinson Disease, Secondary - pathology | Protein Folding - drug effects | Parkinson Disease, Secondary - metabolism | Female | Cell Differentiation | Neurons - metabolism | alpha-Synuclein - genetics | Induced Pluripotent Stem Cells - cytology | Neurons - drug effects | Induced Pluripotent Stem Cells - metabolism | Cell Line | Gene Expression | Antibodies, Monoclonal - pharmacology | Cell Communication | Mice, Transgenic | Mitochondria - metabolism | Mitochondria - drug effects | Mitochondrial Membranes - metabolism | Animals | Parkinson Disease, Secondary - genetics | Mitochondrial Degradation - drug effects | Mitochondrial Membranes - ultrastructure | Mice | Mutation | alpha-Synuclein - metabolism | Cell culture | Membranes | Parkinson's disease | Neurodegenerative diseases | Neurons | Pathogenesis | Fibrils | Transgenic mice | Stem cell transplantation | Exposure | Synuclein | Seeding | Mutants | Pathology | Mitochondria | Rodents | Stem cells | Monoclonal antibodies | Cardiolipin | Aberration | Pluripotency | Movement disorders | Index Medicus
Journal Article
Journal Article
Brain, ISSN 0006-8950, 2012, Volume 135, Issue 11, pp. 3355 - 3370
Axonal degeneration is one of the earliest features of Parkinson's disease pathology, which is followed by neuronal death in the substantia nigra and other... 
axonal degeneration | Parkinson's disease | rho kinase | 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | dopaminergic cell death | CONTROLLED-TRIAL | SIGNALING PATHWAYS | REGENERATION | SUBSTANTIA-NIGRA | NEUROSCIENCES | CLINICAL NEUROLOGY | CELL-DEATH | COENZYME Q | IN-VITRO | 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE MPTP | NEURITE OUTGROWTH | DOUBLE-BLIND | Neuroprotective Agents - therapeutic use | Rats, Wistar | Dopaminergic Neurons - pathology | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine - analogs & derivatives | Male | Corpus Striatum - metabolism | Nerve Degeneration - chemically induced | Neuroprotective Agents - metabolism | rho-Associated Kinases - antagonists & inhibitors | Parkinson Disease, Secondary - pathology | Neuroprotective Agents - pharmacology | Parkinson Disease, Secondary - drug therapy | Dopaminergic Neurons - physiology | Behavior, Animal - drug effects | Parkinson Disease, Secondary - chemically induced | Proto-Oncogene Proteins c-akt - metabolism | Cell Survival - physiology | Dopamine - metabolism | Disease Models, Animal | Substantia Nigra - enzymology | Cell Survival - drug effects | rho-Associated Kinases - physiology | Nerve Degeneration - enzymology | Mice, Inbred C57BL | Cells, Cultured | Axons - drug effects | Rats | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine - therapeutic use | Behavior, Animal - physiology | MPTP Poisoning - drug therapy | MPTP Poisoning - enzymology | Parkinson Disease, Secondary - enzymology | Neurites - pathology | Dopaminergic Neurons - enzymology | Substantia Nigra - drug effects | Animals | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine - pharmacology | Axons - pathology | 1-Methyl-4-phenylpyridinium - toxicity | Mice | Nerve Degeneration - drug therapy | Proto-Oncogene Proteins c-akt - drug effects | Index Medicus | Abridged Index Medicus | Cell culture | Neuroprotection | Animal models | Cell survival | Dopamine | Neurodegenerative diseases | Substantia nigra | Central nervous system | AKT protein | Motor task performance | Rho-associated kinase | Axons | Regeneration | Metabolites | Neurodegeneration | Neostriatum | Axon guidance | Movement disorders
Journal Article
12.